Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Qing Jiaonang (感冒清胶囊) is a traditional Chinese medicine (TCM) herbal capsule integrated with Western medicinal components, developed and manufactured by Guangdong Xinfeng Pharmaceutical. The formulation combines herbal ingredients such as Radix Isatidis, Folium Isatidis, and Herba Andrographis with Western drugs including acetaminophen, moroxydine hydrochloride, and chlorpheniramine maleate. It is indicated for the treatment of wind-heat type common colds and upper respiratory tract infections, effectively addressing symptoms such as fever, headache, nasal congestion, sore throat, and body aches. The herbal components provide heat-clearing and detoxifying effects, while the Western components provide analgesic, antipyretic, antiviral, and antihistamine actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganmao Qing Jiaonang.